U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                   FORM 10-KSB

            [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                 SECURITIES EXCHANGE ACT OF 1934 [Fee Required]
                   For the fiscal year ended February 28, 2001

             [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE
                     SECURITIES EXCHANGE ACT OF 1934 [NO FEE
                       REQUIRED] For the transition period
                             from_______ to________
                         Commission File No. 2-88678-NY

                          MEDI-DATA INTERNATIONAL, INC.
                 (Name of small business issuer in its charter)

       NEW YORK                                             11-2653474
 (State or other jurisdiction                            (I.R.S. Employer
      of incorporation)                                   Identification No.)

                20 RED GROUND ROAD, OLD WESTBURY, NEW YORK 11568
                    (Address of principal executive offices)

                    Issuer's telephone number: (516) 626-0360

       Securities registered under Section 12(b) of the Exchange Act: None
         Securities registered under Section 12(g) of the Exchange Act:

                         COMMON STOCK, $0.001 PAR VALUE
                                (Title of Class)

Check whether the issuer (1) filed all reports required to be filed by section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes [ X ] No [ ]


Number of shares outstanding of the issuer's common equity, as of April 20, 2001
       (exclusive of securities convertible into common equity): 9,212,551



                                       1

<PAGE>


                                     PART I

ITEM 1.  BUSINESS DEVELOPMENT

In  April  1988,  Medi-Data  International,  Inc.  (the  "Company")  ceased  all
operations.  When it was  operating  the Company  had  devoted  its  business to
developing  a program  to monitor  the  interaction  and misuse of  prescription
drugs,  over-the-counter  medication and food  supplements.  For the years ended
February 28, 2001 and 2000,  the Company had no  operations  nor any income from
operations.

The Company is  presently  seeking to acquire an  operating  company  either for
cash,  stock  or a  combination  thereof.  There  is  no  present  agreement  or
understandings  with respect to such a neither  acquisition nor can there be any
assurance that the Company can make such an acquisition in the near future.

ITEM 2.  PROPERTIES
The Company does not lease or own any properties.

ITEM 3.  LEGAL PROCEEDINGS
To the Company's knowledge, there are no legal proceedings pending.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
Not applicable.


                                     PART II

ITEM 5.  MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

ITEM 6.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS

RESULTS OF OPERATIONS
For the year ended  February 28, 2001 and 2000,  the Company has been  inactive.
For the year ended  February  28,  2001 the  Company had a net income of $444 as
compared to a net loss of $130 for the year ended February 29, 2000.

LIQUIDITY AND CAPITAL RESOURCES
The Company ceased all previous operations in April 1988, and therefore, for the
years ended  February 28, 2001 and 2000 the company had no  operations or income
from  operations.  At February 28, 2001 and 2000 the Company had an  accumulated
deficit of $1,059,808 and $1,060,252 respectively.

ITEM 7.  FINANCIAL STATEMENTS
The Company's financial statements are set forth herein.





                                       2

<PAGE>



INDEPENDENT AUDITORS' REPORT



The Board of Directors of
Medi-Data International, Inc.

We have audited the accompanying balance sheet of Medi-Data International,  Inc.
as of February  28, 2001 and 2000,  and the related  statements  of  operations,
stockholders'  deficiency  and  cash  flows  for the  years  then  ended.  These
financial  statements are the  responsibility of the Company's  management.  Our
responsibility  is to express an opinion on these financial  statements based on
our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly in all
material respects, the financial position of Medi-Data International, Inc. as of
February 28, 2001 and 2000 and the results of its  operations and its cash flows
for the years in the period ended,  are in conformity  with  generally  accepted
accounting principles.




Paritz & Company, P.A.
Hackensack, New Jersey
April 24, 2001







                                       3


<PAGE>

<TABLE>
<CAPTION>


                          MEDI-DATA INTERNATIONAL, INC.
                                  BALANCE SHEET
                                  FEBRUARY 28,



                                                                                   2001                  2000
                                                                                   ----                  ----
                                     ASSETS

<S>                                                                          <C>                   <C>
CURRENT ASSETS
       Cash                                                                  $      544            $        0
       Due from shareholder                                                       4,600                 4,600
                                                                             ----------            ----------

TOTAL ASSETS                                                                 $    5,144            $    4,600
                                                                             ==========            ==========


                      LIABILITIES AND SHAREHOLDERS' DEFICIT

CURRENT LIABILITIES
       Accrued expenses and other current liabilities                        $   61,785            $   61,685
                                                                             ----------            ----------

TOTAL CURRENT LIABILITIES                                                        61,785                61,685

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' DEFICIT

       Common stock, $.001 par value 50,000,000 shares
          authorized, 9,213,051 issued and outstanding                            9,213                 9,213
       Additional paid-in capital                                               993,954               993,954
       Accumulated deficit                                                   (1,059,808)           (1,060,252)
                                                                             ----------            ----------

TOTAL SHAREHOLDERS' DEFICIT                                                     (56,641)              (57,085)
                                                                             ----------            ----------


TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT                                  $    5,144            $    4,600
                                                                             ==========            ==========

</TABLE>


                 See accompanying notes to financial statements.


                                       4


<PAGE>

<TABLE>
<CAPTION>

                          MEDI-DATA INTERNATIONAL, INC.
                             STATEMENT OF OPERATIONS
                     FOR THE FISCAL YEARS ENDED FEBRUARY 28,




                                                                                   2001                2000
                                                                                   ----                ----
<S>                                                                           <C>                 <C>
Costs & Expenses:

Selling, general and administrative                                           $       0           $      30
                                                                              ---------           ---------

Loss before other income and state income taxes                                      (0)                (30)
                                                                              ---------           ---------

Other income (expenses):

Other income                                                                        544                  (0)
                                                                              ---------           ---------

Total other income (expense)                                                        544                  (0)
                                                                              ---------           ---------

Income (loss) before state income taxes                                             544                 (30)
                                                                              ---------           ---------

State income taxes                                                                  100                 100
                                                                              ---------           ---------

Net Income (loss)                                                             $     444           $    (130)
                                                                              =========           =========


Income (loss) per share                                                       $  0.0001           $  0.0001
                                                                              =========           =========

Basic and fully diluted shares                                                9,212,551           9,212,551
                                                                              =========           =========

</TABLE>

                 See accompanying notes to financial statements.


                                       5


<PAGE>

<TABLE>
<CAPTION>


                          MEDI-DATA INTERNATIONAL, INC.
                       STATEMENTS OF SHAREHOLDERS' DEFICIT
              FOR THE FISCAL YEARS ENDED FEBRUARY 28, 2001 AND 2000




                                                                       CAPITAL                              TOTAL
                                            COMMON STOCK SHARES       IN EXCESS        ACCUMULATED      SHAREHOLDERS'
                                             SHARES      AMOUNT      OF PAR VALUE        DEFICIT            EQUITY
                                             ------      ------      ------------        -------            ------

 <S>                                       <C>           <C>           <C>             <C>                <C>
 Balance February 28, 1999                 9,212,551     $9,213        $993,954        $(1,060,122)       $(56,955)

 Net loss for the year ended
          February 29, 2000                     -            -             -                  (130)           (130)

                                           ------------------------------------------------------------------------
 Balance February 29, 2000                 9,212,551     $9,213        $993,954        $(1,060,252)       $(57,085)


 Net income for the year ended
  February 28, 2001                             -            -             -                   444             444

                                           ------------------------------------------------------------------------
 Balance February 28, 2001                 9,212,551     $9,213        $993,954        $(1,059,808)       $(56,641)
                                           =========     ======        ========        ============       =========

</TABLE>







                 See accompanying notes to financial statements.


                                       6


<PAGE>

<TABLE>
<CAPTION>


                          MEDI-DATA INTERNATIONAL, INC.
                             STATEMENT OF CASH FLOWS
                     FOR THE FISCAL YEAR ENDED FEBRUARY 28,


                                                                                            2001              2000
                                                                                            ----              ----
<S>                                                                                     <C>               <C>
Cash flows from operating activities:
       Net income (loss)                                                                $   444           $  (130)
                                                                                        -------           -------
       Adjustments to reconcile net loss to net cash provided
       by (used in) operating activities:
       Increase (decrease) in:

       Other assets                                                                          (0)               (0)
                                                                                        -------           -------
       Increase (decrease) in:
       Accrued expenses and other current liabilities                                      (201)              130
                                                                                        -------           -------

                 Net cash provided by operating activities                                  243                (0)
                                                                                        -------           -------

Cash flows from financing activities:
       Advances of shareholders' loans                                                      301                (0)
                                                                                        -------           -------

                 Net cash provided by financing activities                                  301                (0)
                                                                                        -------           -------


       Net increase in cash and equivalent                                                  544                (0)
                                                                                        -------            ------

       Cash and cash equivalents - beginning                                                 (0)               (0)
                                                                                        -------           -------

       Cash and cash equivalents - end                                                  $   544           $    (0)
                                                                                        =======           =======




                       SUPPLEMENTAL CASH FLOW INFORMATION

       Cash paid for interest and taxes was as follows:                                    2001              2000
                                                                                           ----              ----

                                          Interest                                      $     0           $     0
                                                                                        -------           -------

                                          Taxes                                         $   100           $   171
                                                                                        -------           -------

</TABLE>

                 See accompanying notes to financial statements.


                                       7

<PAGE>


                          MEDI-DATA INTERNATIONAL, INC.
                          NOTES TO FINANCIAL STATEMENTS
              FOR THE FISCAL YEARS ENDED FEBRUARY 28, 2001 AND 2000



         1        SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

                  HISTORY

                  The Company is incorporated under the laws of the State of New
                  York.  The Company  ceased all activity  during the year ended
                  February 28, 1989. The current shareholders acquired the stock
                  of the  Company in  September  1994 as a vehicle  to  purchase
                  other  companies,   if  and  when  such  acquisitions   become
                  possible.


                  USE OF ESTIMATES

                  The  preparation  of financial  statements in conformity  with
                  generally accepted  accounting  principles requires management
                  to make  estimates  and  assumptions  that affect the reported
                  amounts of assets and liabilities and disclosure of contingent
                  assets and liabilities at the date of the financial statements
                  and the reported  amounts of revenues and expenses  during the
                  reporting  period.  Actual  results  could  differ  from those
                  estimated.


                  PER SHARE DATA

                  Loss per  share is based on the  weighted  average  number  of
                  shares of common stock outstanding during each period.


         2        INCOME TAXES

                  Federal  income taxes have been offset in full, as the Company
                  has  operating  losses carry  forwards for tax  purposes.  The
                  Company's net operating losses have been substantially reduced
                  in accordance with the Internal Revenue Code 382. State income
                  taxes are based upon capital-based minimum taxes.




                                       8


<PAGE>


                                    PART III


ITEM 9.  DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSON; COMPLIANCE
         WITH SECTION 16(A) OF THE EXCHANGE ACT

The following table sets forth information as of February 28, 2001, with respect
to the officers and directors of the Company.

<TABLE>
<CAPTION>


           NAME                  AGE       YEAR FIRST APPOINTED DIRECTOR           OFFICE HELD
  --------------------------- --------- ------------------------------------ --------------------------
      <S>                        <C>                     <C>                    <C>
         Terry Brooks            48                      1994                        President

  --------------------------- --------- ------------------------------------ --------------------------
       Dawn M. Schlegel          31                      2000                   Secretary/Treasurer

  --------------------------- --------- ------------------------------------ --------------------------
</TABLE>


The term of office for each of the above mentioned  directors is pursuant to the
by-laws  of the  Company,  it will  continue  until the next  annual  meeting of
shareholders and until their respective successors are elected and qualified.


TERRY BROOKS is President and director of the Company. Mrs. Brooks has served as
director  since January 24, 1994 when she became a principal  shareholder of the
Company.  Mrs.  Brooks is principally  engaged in the management of her personal
investments for over five years.

DAWN M.  SCHLEGEL is the Secretary and Treasurer of the Company since January 1,
2000.  Mrs.  Schlegel also serves as the Chief  Financial  Officer of a publicly
traded Company for the past five years.  Mrs. Schlegel became a certified public
accountant  in 1993.  She worked for  Israeloff,  Trattner & Co.  CPA's P.C.,  a
certified public accounting firm for five years prior thereto.


ITEM 10.  EXECUTIVE COMPENSATION
No officer or director of the Company has  received  compensation  as salary for
the years ended February 28, 2001 and 2000.




                                       9

<PAGE>


                          MEDI-DATA INTERNATIONAL, INC.
                          NOTES TO FINANCIAL STATEMENTS
              FOR THE FISCAL YEARS ENDED FEBRUARY 28, 2001 AND 2000



ITEM 11.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth the beneficial  ownership of the Company's common
stock as of April 20, 2001 for each person known by the Company to  beneficially
own more than five percent of the shares of the  outstanding  common stock.  The
Company's directors and officers are listed in Item 9.


   NAME OF INDIVIDUAL                                          % OF OUTSTANDING
   OR IDENTITY OF GROUP          NO. OF SHARES OWNED (1)          COMMON STOCK
   --------------------          -----------------------       ----------------

   Terry Brooks                       5,500,000 (2)                   60%
   Terry Brooks IRA                   2,500,000                       27%
   All officers and Directors         5,500,000 (2)                   60%

(1) Based on the information furnished by the beneficial owners. Except as
otherwise indicated herein, each beneficial owner has sole voting power and sole
investment power with respect to all shares owned.


(2) Includes  3,000,000  shares  held  by Mrs. Brooks as custodian for her minor
children.




ITEM 12.  CERTAIN RELATIONSHIP AND RELATED TRANSACTIONS
None.






                                       10


<PAGE>




SIGNATURES


Pursuant to the  requirements of Section 13 or 15(d) of the Securities  Exchange
Act of 1934,  the  Registrant  has duly  caused  this report to be signed by the
undersigned, thereunto duly authorized.

Dated:  April 20, 2001                        MEDI-DATA INTERNATIONAL, INC.

                                                   /s/TERRY BROOKS
                                                   Terry Brooks, President























                                       11